Wynnewood, PA, United States of America

Kun Yang


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kun Yang: Innovator in Vaccine Composition Quantification

Introduction

Kun Yang is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of vaccine development, particularly in the quantification of viral proteins. With a total of 2 patents, his work has implications for improving vaccine efficacy and safety.

Latest Patents

Kun Yang's latest patents focus on the quantification of vaccine compositions. The first patent provides methods and mass-labeled peptides for quantifying the presence of one or more viral proteins in a sample. This is achieved through mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides. Specifically, the viral proteins targeted are antigens in a vaccine for porcine circovirus. The second patent mirrors the first, emphasizing the same innovative methods and applications in vaccine development.

Career Highlights

Throughout his career, Kun Yang has worked with prominent companies in the veterinary and animal health sectors. He has been associated with Boehringer Ingelheim Vetmedica GmbH and Boehringer Ingelheim Animal Health USA Inc. His experience in these organizations has allowed him to contribute to advancements in veterinary medicine and vaccine technology.

Collaborations

Kun Yang has collaborated with several professionals in his field, including Marc Allan Eichmeyer and Michael B Roof. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in vaccine quantification.

Conclusion

Kun Yang's contributions to vaccine composition quantification highlight his role as an important inventor in the field. His patents and career achievements reflect a commitment to advancing vaccine technology for better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…